CNR1 and colorectal cancer: Thus, dietary EVOO administration reduces the methylation status of rat CNR1 promoter and the expression of miR23A and miR-301a—two modulators of CB1 in the pathogenesis of colorectal cancer, thus inducing the selective expression of CB1 in rat colon.